Related Experiment Video
Updated: Dec 12, 2025

Fluorescence Anisotropy as a Tool to Study Protein-protein Interactions
Published on: October 21, 2016
Insights into changes in binding affinity caused by disease mutations in protein-protein complexes
Sherlyn Jemimah1, M Michael Gromiha2
1Department of Biotechnology, Bhupat and Jyoti Mehta School of Biosciences, Indian Institute of Technology Madras, Chennai, 600036, India.
Mutations affecting protein binding affinity can cause diseases. While many disease mutations lower binding affinity, other factors also influence disease, and some mutations increase affinity, potentially aiding cancer cell survival.
Area of Science:
- Biochemistry
- Molecular Biology
- Genetics
Background:
- Amino acid mutations at protein-protein interfaces alter binding affinity.
- These alterations are implicated in disease development.
Purpose of the Study:
- To systematically analyze the relationship between binding affinity changes and disease-causing mutations.
- To investigate the role of binding affinity in disease mechanisms.
Main Methods:
- Analysis of datasets correlating binding affinity with disease-causing and neutral mutations.
- Structural analysis of protein-protein complexes.
- Examination of mutation effects on non-covalent interactions.
Main Results:
- A significant proportion of disease-causing mutations decrease binding affinity across various datasets.
- The impact of binding affinity on disease varies by disease class.
- Disease-causing mutations often disrupt non-covalent interactions.
- Some mutations increase binding affinity, potentially promoting cancer cell survival.
Conclusions:
- Binding affinity changes are a major factor, but not the sole determinant, in mutation-induced diseases.
- Structural disruptions of non-covalent interactions are key in disease-causing mutations.
- Integrating binding affinity into network studies can elucidate disease mechanisms and identify drug targets.
More Related Videos
Related Concept Videos
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Cooperative Allosteric Transitions
Cooperative Allosteric Transitions
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...

